Pharmaceuticals
Dr. Reddy's Laboratories
Corporate profile and dated shareholding records.
What the company does
Develops and manufactures generics, active pharmaceutical ingredients, innovative medicines and consumer health products.
- Official website
- www.drreddys.com
A shareholder category in this filed snapshot; it is not an individual beneficial owner.
What the disclosure establishes
Filed categories are not individual beneficial owners. Promoter and public categories do not, by themselves, establish ultimate economic ownership or voting control.
Scope. NSE Table I aggregate promoter (A), public (B) and employee-trust (C2) shareholding percentages as of 30 September 2026. Categories are as disclosed and may sum to 99.99% or 100.01% through rounding. The public category includes institutional and other investors; this record does not establish named beneficial ownership or ultimate corporate control.
Ownership composition
Aggregate shareholder categories; not individual beneficial owners.
Original filing and record context
- Original source
- Dr. Reddy's Laboratories, NSE shareholding pattern filed 21 October 2026 for 30 September 2026, Table I
- Observation date
- 2026-09-30
- Disclosure type
- Aggregate categories
- Atlas dataset review
- 2026-11-06
The record reflects the Atlas dataset as indexed, not a newly revalidated exchange filing. The original publisher may have issued subsequent filings. Compare the original document before using these figures for investment, procurement or governance decisions.
Aggregate categories and named holders cannot be combined as if they represented identical kinds of ownership. Filed percentages may be rounded.
Questions about this company
From the dated Atlas record and official sources.
The largest reported category is Public shareholders at 73.17% as of 2026-09-30. This is an aggregate category, not a named beneficial owner. See the original filing.
Develops and manufactures generics, active pharmaceutical ingredients, innovative medicines and consumer health products. Learn more on the official website.
The Atlas has not established a source-verified corporate street address for this record. Consult the official website for current details.
The shareholding snapshot is dated 2026-09-30 and is not live. It may have been superseded by later disclosures. Check the original filing and newer issuer filings.
No. Filing categories identify classes of shareholders, not specific ultimate owners. Equity ownership and voting control may differ. The record's stated scope is: NSE Table I aggregate promoter (A), public (B) and employee-trust (C2) shareholding percentages as of 30 September 2026. Categories are as disclosed and may sum to 99.99% or 100.01% through rounding. The public category includes institutional and other investors; this record does not establish named beneficial ownership or ultimate corporate control.